Elevance Health
1,106 hedge funds and large institutions have $59.3B invested in Elevance Health in 2020 Q2 according to their latest regulatory filings, with 138 funds opening new positions, 392 increasing their positions, 391 reducing their positions, and 76 closing their positions.
82% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 76
17% more capital invested
Capital invested by funds: $50.7B → $59.3B (+$8.6B)
5% more funds holding
Funds holding: 1,051 → 1,106 (+55)
1.11% more ownership
Funds ownership: 88.58% → 89.69% (+1.1%)
0% more repeat investments, than reductions
Existing positions increased: 392 | Existing positions reduced: 391
11% less call options, than puts
Call options by funds: $647M | Put options by funds: $730M
21% less funds holding in top 10
Funds holding in top 10: 34 → 27 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
+$588M |
| 2 |
Eagle Capital Management (New York)
New York
|
+$243M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$167M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$161M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$411M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$215M |
| 3 |
TCI Fund Management
London,
United Kingdom
|
-$196M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$159M |
| 5 |
Lazard Asset Management
New York
|
-$137M |
ELV Hedge Fund Activity: Q2 2020 in Review
1,106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2020, worth a combined $59.3B — up 17% from $50.7B a quarter earlier.
Buyers outnumbered sellers: 138 funds opened new ELV positions and 76 closed out — a net gain of 62 holders — while 392 added to existing stakes and 391 trimmed.
The largest buyer was Nordea Investment Management, adding an estimated $588M. The largest seller was Viking Global Investors, exiting entirely with an estimated $411M sold.
- 1,106 institutional investors held Elevance Health (ELV) as of Q2 2020, up from 1,051 in Q1 2020.
- Funds reported $59.3B of Elevance Health stock for Q2 2020, up 17% quarter-over-quarter.
- 138 funds opened new Elevance Health positions in Q2 2020 and 76 closed out, a net change of +62 holders.
- The largest Elevance Health buyer in Q2 2020 was Nordea Investment Management, an estimated $588M added.
- The largest Elevance Health seller in Q2 2020 was Viking Global Investors, an estimated $411M sold.
Based on aggregated 13F filings for Q2 2020.